REPLIGEN CORP (RGEN) Stock Price, Quote, News and Overview

What is the stock price of REPLIGEN CORP today?

The current stock price of RGEN is 158.99 USD. The price decreased by -2.26% in the last trading session.

What is the ticker symbol for REPLIGEN CORP stock?

The exchange symbol of REPLIGEN CORP is RGEN and it is listed on the Nasdaq exchange.

On which exchange is RGEN stock listed?

RGEN stock is listed on the Nasdaq exchange.

What is the price forecast or stock price prediction for REPLIGEN CORP stock?

24 analysts have analysed RGEN and the average price target is 193.44 USD. This implies a price increase of 21.67% is expected in the next year compared to the current price of 158.99. Check the REPLIGEN CORP stock analysts ratings, price target forecast and up-and down grades for more detailed information.

What is REPLIGEN CORP worth?

REPLIGEN CORP (RGEN) has a market capitalization of 8.91B USD. This makes RGEN a Mid Cap stock.

How many employees does REPLIGEN CORP have?

REPLIGEN CORP (RGEN) currently has 1783 employees.

What are the support and resistance levels for REPLIGEN CORP (RGEN) stock?

REPLIGEN CORP (RGEN) has a support level at 155.65 and a resistance level at 163.68. Check the full technical report for a detailed analysis of RGEN support and resistance levels.

Is REPLIGEN CORP (RGEN) expected to grow?

The Revenue of REPLIGEN CORP (RGEN) is expected to grow by 9.57% in the next year. Check the estimates tab for more information on the RGEN EPS, Sales, EBIT and EBITDA future analyst estimates.

Should I buy REPLIGEN CORP (RGEN) stock?

There is no straightforward answer here. It depends on your investment strategy as different types of investors will look at different aspects. In any case it is important to make an informed decision and these pages can help you forming an opinion:

• The Technical Analysis (TA) tab contains a technical analysis of RGEN, looking at technical quality and support and resistance levels
• The Fundamental Analysis (FA) tab contains a fundamental analysis of RGEN, evaluating the profitability, health, valuation and growth aspects
• REPLIGEN CORP (RGEN) Price Target Forecast and Analysts Ratings to understand what professional analysts say.
• REPLIGEN CORP (RGEN) Sales and EPS estimates to see what analysts future expectations are.
• REPLIGEN CORP (RGEN) Income, Balance Sheet and Cash Flow statements to dive into the historical financials.
• REPLIGEN CORP (RGEN) Insider and Institutional Ownership to learn about the owners and their transactions.
• REPLIGEN CORP (RGEN) Stock Chart to make your own analysis
• REPLIGEN CORP (RGEN) Latest news and press-releases to stay up to date.

Does REPLIGEN CORP (RGEN) stock pay dividends?

RGEN does not pay a dividend.

When does REPLIGEN CORP (RGEN) report earnings?

REPLIGEN CORP (RGEN) will report earnings on 2025-04-29, before the market open.

What is the Price/Earnings (PE) ratio of REPLIGEN CORP (RGEN)?

The PE ratio for REPLIGEN CORP (RGEN) is 107.43. This is based on the reported non-GAAP earnings per share of 1.48 and the current share price of 158.99 USD. Check the full fundamental report for a full analysis of the valuation metrics for RGEN.

What is the Short Interest ratio of REPLIGEN CORP (RGEN) stock?

The outstanding short interest for REPLIGEN CORP (RGEN) is 6.31% of its float. Check the ownership tab for more information on the RGEN short interest.

ChartMill assigns a fundamental rating of 4 / 10 to RGEN. While RGEN has a great health rating, its profitability is only average at the moment.

Over the last trailing twelve months RGEN reported a non-GAAP Earnings per Share(EPS) of 1.48. The EPS decreased by -14.45% compared to the year before.

ChartMill assigns a Buy % Consensus number of 80% to RGEN. The Buy consensus is the average rating of analysts ratings from 24 analysts.

For the next year, analysts expect an EPS growth of 18.8% and a revenue growth 9.57% for RGEN